Clinical Trials at UT Southwestern Medical Center

As of September 2026, 167 paid clinical trials are recruiting at UT Southwestern Medical Center, located at UT Southwestern Medical Center: Research Department, 6000 Harry Hines Blvd, Dallas, TX 75235, phone (214) 633-0022 in Dallas, Texas. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 21, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

169 clinical trials at UT Southwestern Medical Center

·Clear filters·

Get a weekly email when new trials open in Dallas, TX.

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

for Small Cell Lung Cancer (SCLC )

Sites in Dallas, Houston +4 more locations

Sponsor: Moonlight Bio, Inc

Sex: All·Age: 18+

Code: NCT07488923·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease

for Psoriatic Arthritis (PsA)

Drug: Deucravacitinib

1 location in Dallas

Sponsor: University of Texas Southwestern Medical Center

Sex: All·Age: 18 - 65

Code: NCT07280702·Phase 4·Recruiting·Listed Dec 2025

Apply to this trial

Venous Compression in Fontan

for Single-ventricle

1 location in Dallas

Sponsor: University of Texas Southwestern Medical Center

Sex: All·Age: 18 - 45·Accepts healthy volunteers

Code: NCT07220226·Recruiting·Listed Oct 2025

Apply to this trial

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

for Breast Cancer

Sites in Dallas, Houston +10 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT05307705·Phase 1·Recruiting·Listed Apr 2022

Apply to this trial

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

for Pulmonary Arterial Hypertension

Sites in Dallas, Houston +27 more locations

Sponsor: Gossamer Bio USA, Inc.

Sex: All·Age: 18 - 75

Code: NCT06274801·Phase 3·Recruiting·Listed Feb 2024

Apply to this trial

Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST

for Malignant Peripheral Nerve Sheath Tumor (MPNST)

Sites in Dallas +1 more location

Sponsor: AeRang Kim

Sex: All·Age: 18+

Code: NCT06735820·Phase 1, Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

for Diffuse Large B Cell Lymphoma

Sites in Dallas +3 more locations

Sponsor: Kartos Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT04502394·Phase 1, Phase 2·Recruiting·Listed Aug 2020

Apply to this trial